VIA
IONS icon

Virtus Investment Advisers’s Ionis Pharmaceuticals IONS Stock Holding History

Virtus Investment Advisers’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Buy
15,870
+5,425
+52% +$408K 0.29% 168
2026
Q1 		$784K Buy
10,445
+1,991
+24% +$157K 0.22% 165
2025
Q4 		$669K Sell
8,454
-4,022
-32% -$303K 0.18% 192
2025
Q3 		$816K Hold
12,476
– – 0.23% 156
2025
Q2 		$493K Buy
12,476
+2,775
+29% +$90.8K 0.17% 184
2025
Q1 		$293K Buy
+9,701
New +$318K 0.08% 243

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Virtus Investment Advisers's IONS Position: Q2 2026 in Review

Virtus Investment Advisers increased its Ionis Pharmaceuticals (IONS) stake by 52% in Q2 2026, buying an estimated $408K and bringing the position to 15,870 shares worth $1.26M. The position accounts for 0.29% of the portfolio, ranked #168.

Virtus Investment Advisers first reported a position in IONS in Q1 2025 and has held it in 6 quarters since. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Virtus Investment Advisers held 15,870 shares of Ionis Pharmaceuticals worth $1.26M as of Q2 2026.
  • Virtus Investment Advisers bought 5,425 Ionis Pharmaceuticals shares in Q2 2026, an estimated $408K.
  • Ionis Pharmaceuticals made up 0.29% of Virtus Investment Advisers's portfolio in Q2 2026, its #168 holding.
  • Virtus Investment Advisers first reported a position in Ionis Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.